Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
194
-
Total 13F shares, excl. options
-
144M
-
Shares change
-
+2.2M
-
Total reported value, excl. options
-
$704M
-
Value change
-
+$9.7M
-
Put/Call ratio
-
1.74
-
Number of buys
-
84
-
Number of sells
-
-98
-
Price
-
$4.90
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q4 2023
227 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q4 2023.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144M shares
of 152M outstanding shares and own 94.58% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), ARK Investment Management LLC (12.8M shares), VANGUARD GROUP INC (12.8M shares), Matrix Capital Management Company, LP (11.6M shares), BlackRock Inc. (11.4M shares), Nikko Asset Management Americas, Inc. (6.51M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.51M shares), Point72 Asset Management, L.P. (3.72M shares), Pictet Asset Management Holding SA (3.42M shares), and Aristotle Atlantic Partners, LLC (3.05M shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.